Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial

Journal:

Annals of Neurology

Published:

2025-09-01

DOI:

10.1002/ana.27268

Affiliations:

18

Authors:

18

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	2.000000	0.11
Melbourne Brain Centre, Australia	2.000000	0.11
University of Pittsburgh Medical Center (UPMC), United States of America (USA)	2.000000	0.11
UCLA Health, United States of America (USA)	1.000000	0.06
Stanford Health Care, United States of America (USA)	1.000000	0.06
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.06
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.06
Thomas Jefferson University (TJU), United States of America (USA)	1.000000	0.06
National Cerebral and Cardiovascular Center (NCVC), Japan	1.000000	0.06
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.06
Remedy Pharmaceuticals, Inc., United States of America (USA)	1.000000	0.06
University of Maryland, Baltimore (UMB), United States of America (USA)	1.000000	0.06
Yale University, United States of America (USA)	1.000000	0.06
Klinikum Frankfurt-Höchst, Germany	0.500000	0.03
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	0.500000	0.03
Centre Hospitalier Universitaire de Lille (CHU Lille), France	0.333333	0.02
University of Lille (UDL), France	0.333333	0.02
National Institute for Health and Medical Research (INSERM), France	0.333333	0.02

Interested in Neurosciences?